Researchers have identified mutations in the non-coding gene RNU2-2 as a cause of a newly defined neurodevelopmental disorder ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events ...

GenFleet will determine the next steps in development around lymphoma as SELLAS' focus remains on AML and spliceosome-chromatin mutations, including ASXL1 mutations. Raised $25.0 Million of Gross ...

GenFleet will determine the next steps in development around lymphoma as SELLAS’ focus remains on AML and spliceosome–chromatin mutations, including ASXL1 mutations. Raised $25.0 Million of ...

The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results could help pinpoint treatment-resistant tumors. Investigators at ...

That rogue scientist who created HIV-resistant designer babies is apparently gearing up for more human gene-editing research. In an interview with the Wall Street Journal, He Jiankui said he ...

Doctors in China have become the first to report details about a transplant of a genetically modified pig liver into a human. The liver was transplanted last year into a person who was brain-dead ...